2-bromo-N-[3-(trifluoromethyl)phenyl]acetamide, 95.0%, 1g

N-(2,4-Dimethoxybenzyl)-2,5-difluoro-4-(hydroxymethyl)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide, 97%, 100mg

4,4'-(Anthracene-9,10-diyl)dibenzoic acid, 98%, 5g

3-Bromo-6-chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazolo[4,3-c]pyridine, 95.0%, 25g

(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol>98.0%(GC)25g

1-(3-Bromoisoxazol-5-yl)ethanone, 98%, 100mg

5-Bromo-3-chloro-2-ethoxyphenylboronic acid, 98%, 250mg

1,1-Ethanediol Diacetate>98.0%(GC)25g

2-[3-(1H-imidazol-1-yl)propoxy]benzaldehyde hydrochloride, 95.0%, 1g

1-[1-(3-Fluorophenyl)-1H-pyrazol-5-yl]methanamine hydrochloride, 1g

Formamide, min. 99.5%, pa, ACS, 500 ml, glass packaging

1'-(tert-Butoxycarbonyl)-1,4'-bipiperidine-4-carboxylic acid, 97.0%, 5g

5-Chloro-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 97%, 250mg